US20110218525A1 - Preparation For Endovenous Laser Ablation - Google Patents
Preparation For Endovenous Laser Ablation Download PDFInfo
- Publication number
- US20110218525A1 US20110218525A1 US12/877,885 US87788510A US2011218525A1 US 20110218525 A1 US20110218525 A1 US 20110218525A1 US 87788510 A US87788510 A US 87788510A US 2011218525 A1 US2011218525 A1 US 2011218525A1
- Authority
- US
- United States
- Prior art keywords
- vein
- blood
- patient
- leg
- laser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000608 laser ablation Methods 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 210000003462 vein Anatomy 0.000 claims abstract description 118
- 239000008280 blood Substances 0.000 claims abstract description 64
- 210000004369 blood Anatomy 0.000 claims abstract description 64
- 238000001816 cooling Methods 0.000 claims abstract description 9
- 206010002091 Anaesthesia Diseases 0.000 claims description 12
- 230000037005 anaesthesia Effects 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 11
- 206010046996 Varicose vein Diseases 0.000 claims description 10
- 208000005392 Spasm Diseases 0.000 claims description 7
- 230000007246 mechanism Effects 0.000 claims description 7
- 238000002604 ultrasonography Methods 0.000 claims description 7
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 3
- 229930182837 (R)-adrenaline Natural products 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 229960005139 epinephrine Drugs 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 238000000034 method Methods 0.000 abstract description 51
- 230000006835 compression Effects 0.000 abstract description 9
- 238000007906 compression Methods 0.000 abstract description 9
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 208000027185 varicose disease Diseases 0.000 description 8
- 238000002679 ablation Methods 0.000 description 7
- 238000013532 laser treatment Methods 0.000 description 7
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000005526 vasoconstrictor agent Substances 0.000 description 4
- 206010070995 Vascular compression Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 2
- 206010051055 Deep vein thrombosis Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000003099 femoral nerve Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 210000003752 saphenous vein Anatomy 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- 241001640117 Callaeum Species 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/00196—Moving parts reciprocating lengthwise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2255—Optical elements at the distal end of probe tips
- A61B2018/2261—Optical elements at the distal end of probe tips with scattering, diffusion or dispersion of light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/03—Automatic limiting or abutting means, e.g. for safety
- A61B2090/033—Abutting means, stops, e.g. abutting on tissue or skin
- A61B2090/036—Abutting means, stops, e.g. abutting on tissue or skin abutting on tissue or skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
- A61F2007/101—Cooling bags, e.g. ice-bags for cooling organs in the body before or during surgery
Definitions
- the present invention relates generally laser assisted method and apparatus for treatment of varicose veins and, more particularly, to improved methods for preparing a patient to undergo endovenous laser ablation procedures.
- Navarro et al. U.S. Pat. No. 6,398,777, issued Jun. 4, 2002, teaches that it is necessary to have at least some blood in the vein to absorb Diode laser radiation to perform endovenous ablation. More recently, Navarro teaches to remove a significant amount of blood but to leave a layer in the vein to act as an absorbing chromophore for the laser. These lasers in fact will not perform laser ablation of the vein walls with a completely blood free vein.
- Goldman et al. in U.S. Pat. No. 6,752,803, issued Jun. 22, 2004, teach the removal of blood with the use of tumescent anesthesia to compress the vein prior to laser treatment. This method has the disadvantage of not completely removing blood from the vessel. It is generally accepted within the art that the most compression that tumescent anesthesia can accomplish is to bring the vessel to about 5 mm in diameter. At this size, a significant amount of blood can remain in the vessel.
- tumescent anesthesia will only compress the vein to a controlled size
- the use of tumescent anesthesia has proven to be an excellent way to leave a precisely controlled amount of blood in the vein to act as an absorbing chromophore for hemoglobin targeting lasers such as the 810, 940 and 980 nm diode systems.
- any blood remaining in the vessel also has the potential of creating additional problems.
- the blood that remains in the vein may coagulate when heated by the laser and cause thrombosis, non closures, or pain and bruising.
- small pockets of blood act as heat sinks during the laser treatment and need to be heated to coagulation temperatures in order to adequately ablate the vein wall.
- One milliliter of blood can absorb close to one joule of energy to raise its temperature one degree Celsius. Since the damage temperature of the vein wall is around 80 degrees C, it could take as much as 50 Joules of energy to raise this small pocket of blood from 30 deg C.
- the laser treatment dosage is typically only 70 to 80 Jules per centimeter of vein length, so a one milliliter pocket of blood could absorb all of the energy intended to ablate the vein wall in that area leading to a section of non closure of the vein.
- vein wall is perforated during ablation with blood present, blood may leak out of the vein causing bruising and discoloration of the skin post op.
- vein ablation while the vein is shrinking to complete closure, blood left in the vein is squeezed out of the vein through the access point requiring sponging and absorbing pads to clean it up.
- Blood will coagulate at about 80° C. Small pockets of blood that have coagulated and remain in the vein can prevent the vein from completely collapsing on itself. This residual thrombus prevents the opposing coagulated vein walls from touching during the healing process and prevents them from healing together. This is a major cause of non closures and failed procedures.
- Desmyttere et al. described the increased efficacy of endovenous ablation when using a 980 nm diode laser, and when the Trendelenburg position is used to drain the blood prior to treatment.
- DVT deep vein thrombosis
- the present invention is directed to devices and methods for preparing a patient to undergo an endovenous laser ablation procedure.
- the subject devices and methods are intended to facilitate removal of blood from a vein or other vessel undergoing laser ablation prior to the actual ablation procedure. Removal of blood has been found to be beneficial to the patient, both in terms of increasing the efficacy of most laser ablation procedures, and in terms of increasing the safety of most laser ablation procedures.
- the preparation method steps including the following:
- the patient is first given an injection of a femoral blocking anesthetic.
- the venous blood removal procedures (described above) are implemented.
- all compression devices are removed, and tumescent anesthesia is injected along the vein to serve as a heat sink.
- tumescent anesthesia is then performed.
- FIG. 1 is an illustration of a leg of a patient having varicosed veins 200 to be treated according to the methods and apparatus of the present invention.
- FIG. 2 is an illustration of the leg of a patient shown in FIG. 1 , further showing the use of an introducer or dilator 300 with a laser fiber 306 passing through a lumen 302 of the dilator 300 and into the greater saphenous vein 202 .
- FIG. 3 is an illustration of the leg of a patient shown in FIG. 1 , with the leg being positioned in the Trendelenburg position.
- FIG. 4 is an illustration of the leg of a patient shown in FIG. 3 , with a bandage or other wrap applied to the leg.
- FIG. 5 is an illustration of the leg of a patient shown in FIG. 4 undergoing a manual massage.
- FIG. 6 is an illustration of the leg of a patient shown in FIG. 4 , further including an ice pack for cooling.
- FIG. 7 is an illustration of the leg of a patient shown in FIG. 4 , further illustrating the application by injection of a vaso constrictor.
- FIG. 8 is an illustration of the leg of a patient shown in FIG. 2 , further illustrating the use of a suction device on a port of the introducer sheath.
- FIG. 9 is an illustration of the leg of a patient shown in FIG. 2 , further illustrating the use of an ultrasound device.
- the methods for preparing a patient to undergo an endovenous laser ablation procedure are suitable for use with any endovenous laser ablation procedure, but the subject methods find particular application with those procedures for which substantially complete removal of blood from the vein is most beneficial.
- Several prior art endovenous laser ablation procedures are described above, including those taught by Navarro et al. (U.S. Pat. No. 6,398,777) and those taught by Goldman et al. (U.S. Pat. No. 6,752,803). Most preferred are the methods taught by Hennings et al. in U.S. Patent Publication No. 2005/0131400, and those taught by Hennings et al. in U.S. patent application Ser. No. ______, (Attorney Docket No. 15487.4004), filed on behalf of the same assignee and on the same date as the present application.
- Each of the foregoing patents and publications is hereby incorporated by reference in its entirety.
- the methods described herein are intended to remove as much blood as possible from the vein upon which the endovenous laser ablation procedure is to be applied. To that end, the following procedures are used.
- FIG. 1 a varicosed vein 200 to be subjected to an endovenous laser ablation procedure is shown in the leg 201 of the patient.
- a femoral blocking injection is used to provide anesthesia during the endovenous ablation.
- the laser ablation methods taught by Hennings et al. include use of the 1320 nm Nd:YAG laser, which has been shown to be much less painful than prior art devices, and which therefore allows the use of a less invasive single injection to block pain signals traveling along the femoral nerve instead of injecting large amounts of anesthesia all along the vein during a comparable tumescent procedure.
- a 2 inch 22 gauge electrical nerve stimulator needle 500 may be inserted in the groin and the femoral nerve located with electrical stimulus.
- 10-15 ml of bupivacaine with epinephrine is injected to completely block sensation of pain from the lower extremities.
- an introducer sheath or dilator 300 is introduced into the vein by one of several techniques known to those skilled in the art.
- a quartz or sapphire optic fiber 306 is inserted through the lumen 302 of the introducer 300 and into the vein.
- the optic fiber 306 may be inserted directly into the vein 200 via a 16 gauge or similar sized needle, or through the vein 200 which has been externalized through a 2-3 mm incision with a phlebectomy hook (not shown).
- the fiber 306 is preferably from about 500 to about 600 ⁇ m in diameter, but fibers from about 50 ⁇ m or less to about 1 mm or more may be used.
- the optic fiber 306 includes an energy emitting tip 308 through which energy produced by the laser is emitted.
- one or more of the following steps may be performed to drain the vein of blood.
- all of the steps are performed.
- only one or any combination of two or more of these method steps may be performed in order to sufficiently drain the vein of blood.
- the steps are preferably performed in the order described below, alterations of the order of steps are also possible.
- the patient is placed in Trendelenburg position, in which the patient's feet 203 are positioned above the body. This position prevents new blood from entering the vein 202 when the vein is exsanguinated.
- the leg is wrapped with a bandage or flexible wrap 510 to place external compression around the vein to force blood out.
- a bandage or flexible wrap 510 is preferred, the compression of the patient's leg may be applied using any method or device suitable for creating a compression around the vein that is the subject of the laser treatment procedure.
- the vein is next massaged with hand pressure 520 to move blood out of the vein.
- any suitable mechanical massage device may be used to massage the vein such that blood is caused to move out of the vein.
- FIG. 6 shows an ice pack 530 being applied to the leg. Any suitable mechanism or device for applying external cooling will be sufficient, including ice wraps or other external cooling devices.
- the next step includes causing the vein to spasm around the sheath 300 .
- a small amount of a vaso constrictor such as ephinepherine, is injected via 30 gauge needle syringe 540 near the vein. It is preferable not to inject more than about 30 to 50 cc of the vaso constrictor.
- a vaso constrictor such as ephinepherine
- a suction device such as a spring loaded syringe 550 , is attached to an access port 560 in the sheath 300 . See FIG. 8 .
- the suction device may be connected via a separate port if a small access device is used.
- the suction device 550 is used to create a vacuum force that acts to suction out any remaining blood from the vein, completely collapsing the vein around the sheath 300 .
- An ultrasound handpiece 400 which is used for locating the vein and the fiber 306 , can be used to compress the vein and force blood out. See FIG. 9 .
- This process also provides a real time visualization of the effectiveness of the drainage process. For example, when pressure is placed on the skin with the ultrasound head 400 , the vein will change size if it has not been completely compressed. Accordingly, if the vein is visualized under the ultrasound and is shown not to change size under compression, this will serve as an indicator that the vein has been completely compressed and contains no more blood.
- tumescent anesthesia is injected around the vein to provide a heat sink.
- Much less tumescent anesthesia is used in the present method relative to the conventional methods, since the only purpose of the tumescence is to provide a heat sink around the vein.
- the tumescent anesthesia is not needed for the vein compression and blood extraction, as taught, for example, in the Goldman et al. patent. Only 150 to 200 ml of tumescence is needed and a positive pressure is no longer needed around the vein compression. The vein has been previously compressed far beyond what can be done with tumescence alone.
- Reducing the amount of tumescence relative to the prior art procedures also reduces the risk of lidocane reaction in the patient. There is typically a small but significant risk of lidocane overdose in sensitive patients. It is generally accepted in the field that using less than 200 ml of tumescence is adequate for local anesthesia, and as a heat sink, but is not enough to contribute to vein compression.
- the endovenous laser ablation procedure can now proceed according to its normal process.
- the laser ablation procedures described in either of the Navarro et al. patent, the Goldman et al. patent, the Hennings et al. publication, or, most preferably, the U.S. patent application Ser. No. ______ filed Nov. 22, 2006 (Attorney Docket No. 15487.4004) on behalf of the assignee of the present application can be used to ablate the vein. All of the external compression is removed during the laser ablation. Since there is now a complete lack of blood in the vein, there is no need for continued manual compression during the laser exposure.
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Electromagnetism (AREA)
- Otolaryngology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Thermal Sciences (AREA)
- Vascular Medicine (AREA)
- Laser Surgery Devices (AREA)
Abstract
Improved systems and methods for removing blood from a blood vessel in preparation for endovenous laser ablation are described. The improved methods include one or more of: placing the patient in the Trendelenburg position, applying external compression around the vein, massaging the vein, cooling the vein externally, encouraging spasming of the vein, and removing blood with a suction device.
Description
- This Application is continuation of pending U.S. application Ser. No. 11/562,944 filed Nov. 22, 2006, Attorney Docket No. NSL-503, entitled “PREPARATION FOR ENDOVENUOUS LASER ABLATION”, which application is continuation-in-part of pending U.S. application Ser. No. 10/699,212 filed Oct. 30, 2003, Attorney Docket No. NSL-501, entitled “ENDOVENOUS CLOSURE OF VARICOSE VEINS WITH MID INFRARED LASER”, which application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/422,566 filed Oct. 31, 2002, entitled “ENDOVENOUS CLOSURE OF VARICOSE VEINS WITH MID INFRARED LASER”, Attorney Docket No. NSL-501-P, each of which applications is incorporated herein by reference in its entirety. The said U.S. application Ser. No. 11/562,944 filed Nov. 22, 2006, Attorney Docket No. NSL-503, entitled “PREPARATION FOR ENDOVENUOUS LASER ABLATION” is also continuation-in-part of U.S. patent application Ser. No. 10/982,504, filed on Nov. 4, 2004, and titled “ENDOVENOUS CLOSURE OF VARICOSE VEINS WITH MID INFRARED LASER”, Attorney Docket No. 15487.4001/NSL-502, now U.S. Pat. No. 7,524,316, which application is continuation-in-part of and claims the benefit of International Application Number PCT/US2003/035178, filed under the Patent Cooperation Treaty on Oct. 30, 2003, Attorney Docket No. NSL-501-PCT, entitled “ENDOVENOUS CLOSURE OF VARICOSE VEINS WITH MID INFRARED LASER”, designating the United States of America, and titled “ENDOVENOUS CLOSURE OF VARICOSE VEINS WITH MID INFRARED LASER”, which application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/422,566 filed Oct. 31, 2002, entitled “ENDOVENOUS CLOSURE OF VARICOSE VEINS WITH MID INFRARED LASER”, Attorney Docket No. NSL-501-P, each of which applications is incorporated herein by reference in its entirety.
- The present invention relates generally laser assisted method and apparatus for treatment of varicose veins and, more particularly, to improved methods for preparing a patient to undergo endovenous laser ablation procedures.
- Most prior techniques to treat varicose veins have attempted to heat the vessel by targeting the hemoglobin in the blood and then having the heat transfer to the vessel wall. Lasers emitting wavelengths of 500 to 1100 nm have been used for this purpose from both inside the vessel and through the skin Attempts have been made to optimize the laser energy absorption by utilizing local absorption peaks of hemoglobin at 810, 940, 980 and 1064 nm. RF technology has been used to try to heat the vessel wall directly but this technique requires expensive and complicated catheters to deliver electrical energy in direct contact with the vessel wall. Other lasers at 810 nm and 1.06 um have been used in attempts to penetrate the skin and heat the vessel but they also have the disadvantage of substantial hemoglobin absorption which limits the efficiency of heat transfer to the vessel wall, or in the cases where the vessel is drained of blood prior to treatment of excessive transmission through the wall and damage to surrounding tissue. All of these prior techniques result in poor efficiency in heating the collagen in the wall and destroying the endothelial cells.
- For example, Navarro et al., U.S. Pat. No. 6,398,777, issued Jun. 4, 2002, teaches that it is necessary to have at least some blood in the vein to absorb Diode laser radiation to perform endovenous ablation. More recently, Navarro teaches to remove a significant amount of blood but to leave a layer in the vein to act as an absorbing chromophore for the laser. These lasers in fact will not perform laser ablation of the vein walls with a completely blood free vein.
- Goldman et al., in U.S. Pat. No. 6,752,803, issued Jun. 22, 2004, teach the removal of blood with the use of tumescent anesthesia to compress the vein prior to laser treatment. This method has the disadvantage of not completely removing blood from the vessel. It is generally accepted within the art that the most compression that tumescent anesthesia can accomplish is to bring the vessel to about 5 mm in diameter. At this size, a significant amount of blood can remain in the vessel. In fact, since tumescent anesthesia will only compress the vein to a controlled size, the use of tumescent anesthesia has proven to be an excellent way to leave a precisely controlled amount of blood in the vein to act as an absorbing chromophore for hemoglobin targeting lasers such as the 810, 940 and 980 nm diode systems.
- On the other hand, recent attention has been paid to endovenous laser ablation techniques using lasers operating at wavelengths that do not require the presence of blood in the vein. For example, Hennings et al., in U.S. Patent Publication No. 2005/0131400, published on Jun. 16, 2005, teaches that lasers operating at wavelengths of from about 1200 nm to about 1800 nm produce laser energy that is more strongly absorbed by the vessel walls than by the blood, in comparison to the lasers operating at lower wavelengths. Accordingly, the lasers and laser ablation techniques described by Hennings will actually operate better when the vein is drained as far as possible.
- Regardless of the endovenous laser treatment method used, any blood remaining in the vessel also has the potential of creating additional problems. For example, depending upon the laser system components and their operating parameters, the blood that remains in the vein may coagulate when heated by the laser and cause thrombosis, non closures, or pain and bruising. In addition, small pockets of blood act as heat sinks during the laser treatment and need to be heated to coagulation temperatures in order to adequately ablate the vein wall. One milliliter of blood can absorb close to one joule of energy to raise its temperature one degree Celsius. Since the damage temperature of the vein wall is around 80 degrees C, it could take as much as 50 Joules of energy to raise this small pocket of blood from 30 deg C. The laser treatment dosage is typically only 70 to 80 Jules per centimeter of vein length, so a one milliliter pocket of blood could absorb all of the energy intended to ablate the vein wall in that area leading to a section of non closure of the vein.
- Furthermore, if the vein wall is perforated during ablation with blood present, blood may leak out of the vein causing bruising and discoloration of the skin post op.
- Still further, during vein ablation, while the vein is shrinking to complete closure, blood left in the vein is squeezed out of the vein through the access point requiring sponging and absorbing pads to clean it up.
- Blood will coagulate at about 80° C. Small pockets of blood that have coagulated and remain in the vein can prevent the vein from completely collapsing on itself. This residual thrombus prevents the opposing coagulated vein walls from touching during the healing process and prevents them from healing together. This is a major cause of non closures and failed procedures. Desmyttere et al. described the increased efficacy of endovenous ablation when using a 980 nm diode laser, and when the Trendelenburg position is used to drain the blood prior to treatment. See Jacques Desmyttere et al., “A 2 years follow-up study of endovenous 980 nm laser treatment of the great saphenous vein: Role of the blood content in the GSV,” Elsevier, 19 Aug. 2005. They report closure rates of 91% after 2 years when blood is drained compared to closure of only 74% when the patient is in the horizontal position.
- Finally, blood that is coagulated can be forced out of the vein into the remaining venous system and travel through the body as a deep vein thrombosis (DVT). This is a serious and potentially life threatening condition.
- For these reasons, and for the reason that the mid infrared laser does not require a blood chromophore to convert laser energy into thermal energy, it would be desirable to have a method for more completely removing blood from the vein prior to endovenous ablation.
- The present invention is directed to devices and methods for preparing a patient to undergo an endovenous laser ablation procedure. The subject devices and methods are intended to facilitate removal of blood from a vein or other vessel undergoing laser ablation prior to the actual ablation procedure. Removal of blood has been found to be beneficial to the patient, both in terms of increasing the efficacy of most laser ablation procedures, and in terms of increasing the safety of most laser ablation procedures.
- The preparation method steps including the following:
-
- placing the patient in the Trendelenburg position, with the patient's feet elevated above the patient's head, thereby preventing blood from entering the vein after exsanguination;
- compressing the vein, preferably by applying a flexible bandage or other flexible wrap to the exterior of the leg of the patient;
- massaging the vein, either manually or with a suitable electronic medical device;
- cooling the vein, using any suitable cooling device such as an ice pack, ice wrap, or other external cooling device;
- causing the vein to spasm, such as by injection of a suitable vaso constrictor near the vein; and
- suctioning blood out of the vein, such as by connecting and operating a suction device to an access port of a sheath contained within the vein.
- In a preferred embodiment, the patient is first given an injection of a femoral blocking anesthetic. After the anesthetic is administered, the venous blood removal procedures (described above) are implemented. After substantially all of the blood has been removed from the vein, all compression devices are removed, and tumescent anesthesia is injected along the vein to serve as a heat sink. One of any suitable endovenous laser treatment procedures is then performed.
- Further details, objects and advantages of the present invention will be come apparent through the following descriptions, and will be included and incorporated herein.
-
FIG. 1 is an illustration of a leg of a patient having varicosedveins 200 to be treated according to the methods and apparatus of the present invention. -
FIG. 2 is an illustration of the leg of a patient shown inFIG. 1 , further showing the use of an introducer ordilator 300 with alaser fiber 306 passing through alumen 302 of thedilator 300 and into the greatersaphenous vein 202. -
FIG. 3 is an illustration of the leg of a patient shown inFIG. 1 , with the leg being positioned in the Trendelenburg position. -
FIG. 4 is an illustration of the leg of a patient shown inFIG. 3 , with a bandage or other wrap applied to the leg. -
FIG. 5 is an illustration of the leg of a patient shown inFIG. 4 undergoing a manual massage. -
FIG. 6 is an illustration of the leg of a patient shown inFIG. 4 , further including an ice pack for cooling. -
FIG. 7 is an illustration of the leg of a patient shown inFIG. 4 , further illustrating the application by injection of a vaso constrictor. -
FIG. 8 is an illustration of the leg of a patient shown inFIG. 2 , further illustrating the use of a suction device on a port of the introducer sheath. -
FIG. 9 is an illustration of the leg of a patient shown inFIG. 2 , further illustrating the use of an ultrasound device. - The description that follows is presented to enable one skilled in the art to make and use the present invention, and is provided in the context of a particular application and its requirements. Various modifications to the disclosed embodiments will be apparent to those skilled in the art, and the general principles discussed below may be applied to other embodiments and applications without departing from the scope and spirit of the invention. Therefore, the invention is not intended to be limited to the embodiments disclosed, but the invention is to be given the largest possible scope which is consistent with the principles and features described herein.
- It will be understood that in the event parts of different embodiments have similar functions or uses, they may have been given similar or identical reference numerals and descriptions. It will be understood that such duplication of reference numerals is intended solely for efficiency and ease of understanding the present invention, and are not to be construed as limiting in any way, or as implying that the various embodiments themselves are identical.
- The methods for preparing a patient to undergo an endovenous laser ablation procedure are suitable for use with any endovenous laser ablation procedure, but the subject methods find particular application with those procedures for which substantially complete removal of blood from the vein is most beneficial. Several prior art endovenous laser ablation procedures are described above, including those taught by Navarro et al. (U.S. Pat. No. 6,398,777) and those taught by Goldman et al. (U.S. Pat. No. 6,752,803). Most preferred are the methods taught by Hennings et al. in U.S. Patent Publication No. 2005/0131400, and those taught by Hennings et al. in U.S. patent application Ser. No. ______, (Attorney Docket No. 15487.4004), filed on behalf of the same assignee and on the same date as the present application. Each of the foregoing patents and publications is hereby incorporated by reference in its entirety.
- The methods described herein are intended to remove as much blood as possible from the vein upon which the endovenous laser ablation procedure is to be applied. To that end, the following procedures are used.
- Turning first to
FIG. 1 , avaricosed vein 200 to be subjected to an endovenous laser ablation procedure is shown in theleg 201 of the patient. A femoral blocking injection is used to provide anesthesia during the endovenous ablation. The laser ablation methods taught by Hennings et al. include use of the 1320 nm Nd:YAG laser, which has been shown to be much less painful than prior art devices, and which therefore allows the use of a less invasive single injection to block pain signals traveling along the femoral nerve instead of injecting large amounts of anesthesia all along the vein during a comparable tumescent procedure. In the preferred method, a 2 inch 22 gauge electricalnerve stimulator needle 500 may be inserted in the groin and the femoral nerve located with electrical stimulus. When the nerve is located, 10-15 ml of bupivacaine with epinephrine is injected to completely block sensation of pain from the lower extremities. - Next, as shown in
FIG. 2 , access to the vein is performed prior to draining the vein of blood. Once an access sheath is in place and the fiber is inserted into the vein, the vein can be drained without affecting the ability to get the fiber in position. An introducer sheath ordilator 300 is introduced into the vein by one of several techniques known to those skilled in the art. A quartz orsapphire optic fiber 306 is inserted through thelumen 302 of theintroducer 300 and into the vein. Alternatively, theoptic fiber 306 may be inserted directly into thevein 200 via a 16 gauge or similar sized needle, or through thevein 200 which has been externalized through a 2-3 mm incision with a phlebectomy hook (not shown). Thefiber 306 is preferably from about 500 to about 600 μm in diameter, but fibers from about 50 μm or less to about 1 mm or more may be used. Theoptic fiber 306 includes anenergy emitting tip 308 through which energy produced by the laser is emitted. - Once the
access sheath 300 is in place, one or more of the following steps may be performed to drain the vein of blood. In a preferred method, all of the steps are performed. However, as explained more fully below, it is also contemplated that, for a given patient or a given set of circumstances, only one or any combination of two or more of these method steps may be performed in order to sufficiently drain the vein of blood. Although the steps are preferably performed in the order described below, alterations of the order of steps are also possible. - First, as illustrated in
FIG. 3 , the patient is placed in Trendelenburg position, in which the patient'sfeet 203 are positioned above the body. This position prevents new blood from entering thevein 202 when the vein is exsanguinated. - Next, as shown in
FIG. 4 , the leg is wrapped with a bandage orflexible wrap 510 to place external compression around the vein to force blood out. Although a bandage orflexible wrap 510 is preferred, the compression of the patient's leg may be applied using any method or device suitable for creating a compression around the vein that is the subject of the laser treatment procedure. - Turning to
FIG. 5 , the vein is next massaged withhand pressure 520 to move blood out of the vein. Alternatively, any suitable mechanical massage device may be used to massage the vein such that blood is caused to move out of the vein. - Next, the leg is cooled from the exterior.
FIG. 6 shows anice pack 530 being applied to the leg. Any suitable mechanism or device for applying external cooling will be sufficient, including ice wraps or other external cooling devices. - Turning to
FIG. 7 , the next step includes causing the vein to spasm around thesheath 300. In the preferred method, a small amount of a vaso constrictor, such as ephinepherine, is injected via 30gauge needle syringe 540 near the vein. It is preferable not to inject more than about 30 to 50 cc of the vaso constrictor. As the vein spasms around thesheath 300, it causes any remaining blood contained within the vein to be forced out of the vein. - Next, a suction device, such as a spring loaded
syringe 550, is attached to anaccess port 560 in thesheath 300. SeeFIG. 8 . Alternatively, the suction device may be connected via a separate port if a small access device is used. Once attached, thesuction device 550 is used to create a vacuum force that acts to suction out any remaining blood from the vein, completely collapsing the vein around thesheath 300. - An
ultrasound handpiece 400, which is used for locating the vein and thefiber 306, can be used to compress the vein and force blood out. SeeFIG. 9 . This process also provides a real time visualization of the effectiveness of the drainage process. For example, when pressure is placed on the skin with theultrasound head 400, the vein will change size if it has not been completely compressed. Accordingly, if the vein is visualized under the ultrasound and is shown not to change size under compression, this will serve as an indicator that the vein has been completely compressed and contains no more blood. - Once all of the blood is removed, as evidenced by the vein being completely collapsed under ultrasound examination, then tumescent anesthesia is injected around the vein to provide a heat sink Much less tumescent anesthesia is used in the present method relative to the conventional methods, since the only purpose of the tumescence is to provide a heat sink around the vein. In particular, the tumescent anesthesia is not needed for the vein compression and blood extraction, as taught, for example, in the Goldman et al. patent. Only 150 to 200 ml of tumescence is needed and a positive pressure is no longer needed around the vein compression. The vein has been previously compressed far beyond what can be done with tumescence alone. Reducing the amount of tumescence relative to the prior art procedures also reduces the risk of lidocane reaction in the patient. There is typically a small but significant risk of lidocane overdose in sensitive patients. It is generally accepted in the field that using less than 200 ml of tumescence is adequate for local anesthesia, and as a heat sink, but is not enough to contribute to vein compression.
- The endovenous laser ablation procedure can now proceed according to its normal process. For example, the laser ablation procedures described in either of the Navarro et al. patent, the Goldman et al. patent, the Hennings et al. publication, or, most preferably, the U.S. patent application Ser. No. ______ filed Nov. 22, 2006 (Attorney Docket No. 15487.4004) on behalf of the assignee of the present application, can be used to ablate the vein. All of the external compression is removed during the laser ablation. Since there is now a complete lack of blood in the vein, there is no need for continued manual compression during the laser exposure.
- Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present invention belongs. Although any methods and materials similar or equivalent to those described can be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications and patent documents referenced in the present invention are incorporated herein by reference.
- While the principles of the invention have been made clear in illustrative embodiments, there will be immediately obvious to those skilled in the art many modifications of structure, arrangement, proportions, elements, materials, and components used in the practice of the invention, and otherwise, which are particularly adapted to specific environments and operative requirements without departing from those principles. The appended claims are intended to cover and embrace any and all such modifications, with the limits only of the true purview, spirit and scope of the invention.
Claims (26)
1. An endovenous system for treating a varicose vein of a patient, the system comprising a laser having a wavelength between about 1.2 and 2.5 um to heat and shrink collagen, a mechanism for exsanguinating the varicosed vein, and an endovenous fiber optic laser delivery device for endovenously transmitting the laser energy directly into the varicosed vein.
2. The system of claim 1 , wherein the mechanism for exsanguinating the varicosed vein is apparatus for maintaining the patient in the Trendelenburg position.
3. The system of claim 1 , wherein the mechanism for exsanguinating the varicosed vein is a flexible bandage suitable for wrapping the leg of the patient, thereby forcing blood out of the vein.
4. The system of claim 1 , wherein the mechanism for exsanguinating the varicosed vein is a massage device, wherein when the massage device is applied externally to the leg of the patient, blood will be exsanguinated from the vein.
5. The system of claim 1 , wherein the mechanism for exsanguinating the varicosed vein is a cooling device for cooling the leg of a patient, thereby causing the vein to constrict.
6. The system of claim 1 , wherein an ultrasound handpiece is used to compress the vein and visually determine if any blood is left in the vein.
7. The system of claim 1 , further comprising means to cause the vein to spasm, thereby causing constriction of the vein.
8. The system of claim 7 , wherein the vein spasm is caused by vibrating or moving a catheter when it is inside the vein.
9. The system of claim 7 , wherein a vasoconstricting drug is applied near the vein, thereby causing the vein to constrict.
10. The system of claim 9 , wherein the vasoconstricting drug comprises epinephrine.
11. The system of claim 1 , wherein a suction device is used to remove blood from the vein.
12. The system of claim 3 , wherein said flexible bandage is removed after the blood is removed from the vein, after tumescent anesthesia is injected, and prior to an endovenous laser ablation being performed on said vein.
13. The system of claim 1 , wherein a femoral block is injected into the leg of the patient.
14. An endovenous system of treating a varicose vein of a patient, the system comprising using a laser having a wavelength between about 1.2 and 2.5 um to heat and shrink collagen in a varicosed vessel, the laser energy transmitted via fiber optic laser delivery device directly into the varicosed vein from which blood has been sufficiently drained.
15. The system of claim 14 , wherein blood is removed from the vein by placing the patient in the Trendelenburg position.
16. The system of claim 14 , wherein a leg of the patient is wrapped in a flexible bandage, thereby forcing blood out of the vein.
17. The system of claim 14 , wherein the vein is massaged externally by hand to exsanguinate blood from the vein.
18. The system of claim 14 , wherein the leg is cooled, thereby causing the vein to constrict.
19. The system of claim 14 , wherein an ultrasound handpiece is used to compress the vein and visually determine if any blood is left in the vein.
20. The system of claim 14 , further comprising mechanism for causing the vain to spasm, thereby causing constriction of the vein.
21. The system of claim 20 , wherein the vein spasm is caused by vibrating or moving a catheter when it is inside the vein.
22. The system of claim 14 , wherein a vasoconstricting drug is applied near the vein, thereby causing the vein to constrict.
23. The system of claim 22 , wherein said vasoconstricting drug comprises epinephrine.
24. The system of claim 14 , wherein a suction device is used to remove blood from the vein.
25. The system of claim 16 , wherein said flexible bandage is removed after the blood is removed from the vein, after tumescent anesthesia is injected, and prior to an endovenous laser ablation being performed on said vein.
26. The system of claim 14 , wherein a femoral block is injected into the leg of the patient.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/877,885 US20110218525A1 (en) | 2002-10-31 | 2010-09-08 | Preparation For Endovenous Laser Ablation |
US14/920,308 US20160113714A1 (en) | 2002-10-31 | 2015-10-22 | Preparation For Endovenous Laser Ablation |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42256602P | 2002-10-31 | 2002-10-31 | |
PCT/US2003/035178 WO2004039435A2 (en) | 2002-10-31 | 2003-10-30 | Endovenous closure of varicose veins with mid infrared laser |
US10/699,212 US20040092913A1 (en) | 2002-10-31 | 2003-10-30 | Endovenous closure of varicose veins with mid infrared laser |
US10/982,504 US7524316B2 (en) | 2002-10-31 | 2004-11-04 | Endovenous closure of varicose veins with mid infrared laser |
US11/562,944 US7921854B2 (en) | 2002-10-31 | 2006-11-22 | Endovenous laser treatment for varicose veins |
US12/877,885 US20110218525A1 (en) | 2002-10-31 | 2010-09-08 | Preparation For Endovenous Laser Ablation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/562,944 Continuation US7921854B2 (en) | 2002-10-31 | 2006-11-22 | Endovenous laser treatment for varicose veins |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/920,308 Continuation US20160113714A1 (en) | 2002-10-31 | 2015-10-22 | Preparation For Endovenous Laser Ablation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110218525A1 true US20110218525A1 (en) | 2011-09-08 |
Family
ID=46326666
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/562,944 Expired - Fee Related US7921854B2 (en) | 2002-10-31 | 2006-11-22 | Endovenous laser treatment for varicose veins |
US12/877,885 Abandoned US20110218525A1 (en) | 2002-10-31 | 2010-09-08 | Preparation For Endovenous Laser Ablation |
US14/920,308 Abandoned US20160113714A1 (en) | 2002-10-31 | 2015-10-22 | Preparation For Endovenous Laser Ablation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/562,944 Expired - Fee Related US7921854B2 (en) | 2002-10-31 | 2006-11-22 | Endovenous laser treatment for varicose veins |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/920,308 Abandoned US20160113714A1 (en) | 2002-10-31 | 2015-10-22 | Preparation For Endovenous Laser Ablation |
Country Status (1)
Country | Link |
---|---|
US (3) | US7921854B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238453B2 (en) | 2002-07-10 | 2019-03-26 | Angiodynamics, Inc. | Method of making an endovascular laser treatment device for causing closure of a blood vessel |
US10322296B2 (en) | 2009-07-20 | 2019-06-18 | Syneron Medical Ltd. | Method and apparatus for fractional skin treatment |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7921854B2 (en) * | 2002-10-31 | 2011-04-12 | Cooltouch Incorporated | Endovenous laser treatment for varicose veins |
US7644715B2 (en) | 2002-10-31 | 2010-01-12 | Cooltouch, Incorporated | Restless leg syndrome treatment |
US9867530B2 (en) | 2006-08-14 | 2018-01-16 | Volcano Corporation | Telescopic side port catheter device with imaging system and method for accessing side branch occlusions |
US8448644B2 (en) * | 2006-11-02 | 2013-05-28 | Cooltouch Incorporated | Sonic endovenous catheter |
US9596993B2 (en) | 2007-07-12 | 2017-03-21 | Volcano Corporation | Automatic calibration systems and methods of use |
WO2009009799A1 (en) | 2007-07-12 | 2009-01-15 | Volcano Corporation | Catheter for in vivo imaging |
US10219780B2 (en) | 2007-07-12 | 2019-03-05 | Volcano Corporation | OCT-IVUS catheter for concurrent luminal imaging |
US20090248011A1 (en) * | 2008-02-28 | 2009-10-01 | Hlavka Edwin J | Chronic venous insufficiency treatment |
US20100234832A1 (en) * | 2009-03-13 | 2010-09-16 | Ferreira Julio H G | Method for vascular treatment |
WO2011084863A2 (en) | 2010-01-07 | 2011-07-14 | Cheetah Omni, Llc | Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy |
US11141063B2 (en) | 2010-12-23 | 2021-10-12 | Philips Image Guided Therapy Corporation | Integrated system architectures and methods of use |
US11040140B2 (en) | 2010-12-31 | 2021-06-22 | Philips Image Guided Therapy Corporation | Deep vein thrombosis therapeutic methods |
BR112013021463A2 (en) | 2011-02-24 | 2016-11-01 | Eximo Medical Ltd | tissue resection hybrid catheter |
US8992513B2 (en) | 2011-06-30 | 2015-03-31 | Angiodynamics, Inc | Endovascular plasma treatment device and method of use |
WO2013033489A1 (en) | 2011-08-31 | 2013-03-07 | Volcano Corporation | Optical rotary joint and methods of use |
US9307926B2 (en) | 2012-10-05 | 2016-04-12 | Volcano Corporation | Automatic stent detection |
US9858668B2 (en) | 2012-10-05 | 2018-01-02 | Volcano Corporation | Guidewire artifact removal in images |
US9367965B2 (en) | 2012-10-05 | 2016-06-14 | Volcano Corporation | Systems and methods for generating images of tissue |
US9286673B2 (en) | 2012-10-05 | 2016-03-15 | Volcano Corporation | Systems for correcting distortions in a medical image and methods of use thereof |
JP2015532536A (en) | 2012-10-05 | 2015-11-09 | デイビッド ウェルフォード, | System and method for amplifying light |
US11272845B2 (en) | 2012-10-05 | 2022-03-15 | Philips Image Guided Therapy Corporation | System and method for instant and automatic border detection |
US10070827B2 (en) | 2012-10-05 | 2018-09-11 | Volcano Corporation | Automatic image playback |
US9292918B2 (en) | 2012-10-05 | 2016-03-22 | Volcano Corporation | Methods and systems for transforming luminal images |
US9324141B2 (en) | 2012-10-05 | 2016-04-26 | Volcano Corporation | Removal of A-scan streaking artifact |
US10568586B2 (en) | 2012-10-05 | 2020-02-25 | Volcano Corporation | Systems for indicating parameters in an imaging data set and methods of use |
US9840734B2 (en) | 2012-10-22 | 2017-12-12 | Raindance Technologies, Inc. | Methods for analyzing DNA |
EP2931132B1 (en) | 2012-12-13 | 2023-07-05 | Philips Image Guided Therapy Corporation | System for targeted cannulation |
US10942022B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Manual calibration of imaging system |
EP2934311B1 (en) | 2012-12-20 | 2020-04-15 | Volcano Corporation | Smooth transition catheters |
EP2934282B1 (en) | 2012-12-20 | 2020-04-29 | Volcano Corporation | Locating intravascular images |
US11406498B2 (en) | 2012-12-20 | 2022-08-09 | Philips Image Guided Therapy Corporation | Implant delivery system and implants |
US10939826B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Aspirating and removing biological material |
CA2895989A1 (en) | 2012-12-20 | 2014-07-10 | Nathaniel J. Kemp | Optical coherence tomography system that is reconfigurable between different imaging modes |
CA2895990A1 (en) | 2012-12-21 | 2014-06-26 | Jerome MAI | Ultrasound imaging with variable line density |
US9486143B2 (en) | 2012-12-21 | 2016-11-08 | Volcano Corporation | Intravascular forward imaging device |
EP2934653B1 (en) | 2012-12-21 | 2018-09-19 | Douglas Meyer | Rotational ultrasound imaging catheter with extended catheter body telescope |
US9612105B2 (en) | 2012-12-21 | 2017-04-04 | Volcano Corporation | Polarization sensitive optical coherence tomography system |
US10058284B2 (en) | 2012-12-21 | 2018-08-28 | Volcano Corporation | Simultaneous imaging, monitoring, and therapy |
US9383263B2 (en) | 2012-12-21 | 2016-07-05 | Volcano Corporation | Systems and methods for narrowing a wavelength emission of light |
JP2016501623A (en) | 2012-12-21 | 2016-01-21 | アンドリュー ハンコック, | System and method for multipath processing of image signals |
WO2014099763A1 (en) | 2012-12-21 | 2014-06-26 | Jason Spencer | System and method for graphical processing of medical data |
WO2014100162A1 (en) | 2012-12-21 | 2014-06-26 | Kemp Nathaniel J | Power-efficient optical buffering using optical switch |
US10413317B2 (en) | 2012-12-21 | 2019-09-17 | Volcano Corporation | System and method for catheter steering and operation |
US9770172B2 (en) | 2013-03-07 | 2017-09-26 | Volcano Corporation | Multimodal segmentation in intravascular images |
US10226597B2 (en) | 2013-03-07 | 2019-03-12 | Volcano Corporation | Guidewire with centering mechanism |
EP2967391A4 (en) | 2013-03-12 | 2016-11-02 | Donna Collins | Systems and methods for diagnosing coronary microvascular disease |
US20140276923A1 (en) | 2013-03-12 | 2014-09-18 | Volcano Corporation | Vibrating catheter and methods of use |
US11026591B2 (en) | 2013-03-13 | 2021-06-08 | Philips Image Guided Therapy Corporation | Intravascular pressure sensor calibration |
US9301687B2 (en) | 2013-03-13 | 2016-04-05 | Volcano Corporation | System and method for OCT depth calibration |
JP6339170B2 (en) | 2013-03-13 | 2018-06-06 | ジンヒョン パーク | System and method for generating images from a rotating intravascular ultrasound device |
US10426590B2 (en) | 2013-03-14 | 2019-10-01 | Volcano Corporation | Filters with echogenic characteristics |
US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
US20150250536A1 (en) * | 2014-03-10 | 2015-09-10 | Terumo Kabushiki Kaisha | Method for treating varicose veins and intraluminal device used in such method |
US20150250523A1 (en) * | 2014-03-10 | 2015-09-10 | Terumo Kabushiki Kaisha | Method for treating varicose veins and intraluminal device used in such method |
US20150250522A1 (en) * | 2014-03-10 | 2015-09-10 | Terumo Kabushiki Kaisha | Method for treating varicose veins and intraluminal device used in such method |
CN112869873A (en) | 2014-03-26 | 2021-06-01 | 文科罗斯公司 | Treatment of venous diseases |
WO2017191644A1 (en) | 2016-05-05 | 2017-11-09 | Eximo Medical Ltd | Apparatus and methods for resecting and/or ablating an undesired tissue |
EP3720356A1 (en) | 2017-12-08 | 2020-10-14 | Theraclion SA | Ultrasound device |
US12038322B2 (en) | 2022-06-21 | 2024-07-16 | Eximo Medical Ltd. | Devices and methods for testing ablation systems |
Citations (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233991A (en) * | 1978-12-18 | 1980-11-18 | American Medical Systems, Inc. | Urethral catheter puller |
US4854320A (en) * | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US4899741A (en) * | 1987-01-14 | 1990-02-13 | Hgm Medical Laser Systems, Inc. | Laser heated probe and control system |
US5022399A (en) * | 1989-05-10 | 1991-06-11 | Biegeleisen Ken P | Venoscope |
US5196004A (en) * | 1985-07-31 | 1993-03-23 | C. R. Bard, Inc. | Infrared laser catheter system |
US5207672A (en) * | 1989-05-03 | 1993-05-04 | Intra-Sonix, Inc. | Instrument and method for intraluminally relieving stenosis |
US5301688A (en) * | 1992-08-07 | 1994-04-12 | Physion S.R.L. | Method for localization and therapy of occult bladder cancer |
US5707403A (en) * | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
US5789755A (en) * | 1996-08-28 | 1998-08-04 | New Star Lasers, Inc. | Method and apparatus for removal of material utilizing near-blackbody radiator means |
US5810801A (en) * | 1997-02-05 | 1998-09-22 | Candela Corporation | Method and apparatus for treating wrinkles in skin using radiation |
US5820626A (en) * | 1996-07-30 | 1998-10-13 | Laser Aesthetics, Inc. | Cooling laser handpiece with refillable coolant reservoir |
US5824005A (en) * | 1995-08-22 | 1998-10-20 | Board Of Regents, The University Of Texas System | Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias |
US5885274A (en) * | 1997-06-24 | 1999-03-23 | New Star Lasers, Inc. | Filament lamp for dermatological treatment |
US5968034A (en) * | 1997-06-24 | 1999-10-19 | Laser Aesthetics, Inc. | Pulsed filament lamp for dermatological treatment |
US5976123A (en) * | 1996-07-30 | 1999-11-02 | Laser Aesthetics, Inc. | Heart stabilization |
US5984915A (en) * | 1997-10-08 | 1999-11-16 | Trimedyne, Inc. | Percutaneous laser treatment |
US6014589A (en) * | 1997-11-12 | 2000-01-11 | Vnus Medical Technologies, Inc. | Catheter having expandable electrodes and adjustable stent |
US6033398A (en) * | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency using directionally applied energy |
US6083223A (en) * | 1997-08-28 | 2000-07-04 | Baker; James A. | Methods and apparatus for welding blood vessels |
US6117335A (en) * | 1998-02-23 | 2000-09-12 | New Star Lasers, Inc. | Decontamination of water by photolytic oxidation/reduction utilizing near blackbody radiation |
US6135997A (en) * | 1996-03-05 | 2000-10-24 | Vnus Medical Technologies, Inc. | Method for treating hemorrhoids |
US6176854B1 (en) * | 1997-10-08 | 2001-01-23 | Robert Roy Cone | Percutaneous laser treatment |
US6197020B1 (en) * | 1996-08-12 | 2001-03-06 | Sublase, Inc. | Laser apparatus for subsurface cutaneous treatment |
US6200332B1 (en) * | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
US6206873B1 (en) * | 1996-02-13 | 2001-03-27 | El. En. S.P.A. | Device and method for eliminating adipose layers by means of laser energy |
US6224593B1 (en) * | 1999-01-13 | 2001-05-01 | Sherwood Services Ag | Tissue sealing using microwaves |
US6228078B1 (en) * | 1995-11-22 | 2001-05-08 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
US6258084B1 (en) * | 1997-09-11 | 2001-07-10 | Vnus Medical Technologies, Inc. | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US6270476B1 (en) * | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6273883B1 (en) * | 1996-04-09 | 2001-08-14 | Cynosure, Inc. | Alexandrite laser system for treatment of dermatological specimens |
US6273885B1 (en) * | 1997-08-16 | 2001-08-14 | Cooltouch Corporation | Handheld photoepilation device and method |
US6290675B1 (en) * | 1997-01-09 | 2001-09-18 | Endosonics Corporation | Device for withdrawing a catheter |
US6306130B1 (en) * | 1998-04-07 | 2001-10-23 | The General Hospital Corporation | Apparatus and methods for removing blood vessels |
US6346105B1 (en) * | 1998-07-27 | 2002-02-12 | Quantum Cor Incorporated | Device for treating tissue and methods thereof |
US6361496B1 (en) * | 1997-06-02 | 2002-03-26 | Vnus Medical Technologies, Inc. | Pressure tourniquet with ultrasound window and method of use |
US6398777B1 (en) * | 1999-02-01 | 2002-06-04 | Luis Navarro | Endovascular laser device and treatment of varicose veins |
US6413253B1 (en) * | 1997-08-16 | 2002-07-02 | Cooltouch Corporation | Subsurface heating of material |
US6451044B1 (en) * | 1996-09-20 | 2002-09-17 | Board Of Regents, The University Of Texas System | Method and apparatus for heating inflammed tissue |
US6451007B1 (en) * | 1999-07-29 | 2002-09-17 | Dale E. Koop | Thermal quenching of tissue |
US6520975B2 (en) * | 1999-02-04 | 2003-02-18 | Antonio Carlos Branco | Kit for endovascular venous surgery |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6638273B1 (en) * | 1996-03-05 | 2003-10-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
US20040010248A1 (en) * | 2002-07-10 | 2004-01-15 | Appling William M. | Endovascular treatment device having a fiber tip spacer |
US6761826B2 (en) * | 2001-11-30 | 2004-07-13 | New Star Lasers, Inc. | Pulsed blackbody radiation flux enhancement |
US7160289B2 (en) * | 2003-03-28 | 2007-01-09 | Vandolay, Inc. | Vascular occlusion systems and methods |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US603398A (en) * | 1898-05-03 | Arthur dalmer | ||
EP0582686B1 (en) | 1991-04-05 | 1998-08-12 | Indigo Medical, Incorporated | Apparatus using a laser lucent needle |
MX9300607A (en) | 1992-02-06 | 1993-10-01 | American Med Syst | APPARATUS AND METHOD FOR INTERSTITIAL TREATMENT. |
US6396777B1 (en) * | 2000-05-30 | 2002-05-28 | Delphi Technologies, Inc. | Compact disk player instant-on feature |
JP3944816B2 (en) * | 2001-01-31 | 2007-07-18 | ミネベア株式会社 | Surface lighting device |
US6986766B2 (en) * | 2001-06-15 | 2006-01-17 | Diomed Inc. | Method of endovenous laser treatment |
US7921854B2 (en) * | 2002-10-31 | 2011-04-12 | Cooltouch Incorporated | Endovenous laser treatment for varicose veins |
US7524316B2 (en) * | 2002-10-31 | 2009-04-28 | Cooltouch, Inc. | Endovenous closure of varicose veins with mid infrared laser |
US20040092913A1 (en) * | 2002-10-31 | 2004-05-13 | Hennings David R. | Endovenous closure of varicose veins with mid infrared laser |
US9132031B2 (en) * | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
-
2006
- 2006-11-22 US US11/562,944 patent/US7921854B2/en not_active Expired - Fee Related
-
2010
- 2010-09-08 US US12/877,885 patent/US20110218525A1/en not_active Abandoned
-
2015
- 2015-10-22 US US14/920,308 patent/US20160113714A1/en not_active Abandoned
Patent Citations (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233991A (en) * | 1978-12-18 | 1980-11-18 | American Medical Systems, Inc. | Urethral catheter puller |
US4854320A (en) * | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US5196004A (en) * | 1985-07-31 | 1993-03-23 | C. R. Bard, Inc. | Infrared laser catheter system |
US4899741A (en) * | 1987-01-14 | 1990-02-13 | Hgm Medical Laser Systems, Inc. | Laser heated probe and control system |
US5207672A (en) * | 1989-05-03 | 1993-05-04 | Intra-Sonix, Inc. | Instrument and method for intraluminally relieving stenosis |
US5022399A (en) * | 1989-05-10 | 1991-06-11 | Biegeleisen Ken P | Venoscope |
US5301688A (en) * | 1992-08-07 | 1994-04-12 | Physion S.R.L. | Method for localization and therapy of occult bladder cancer |
US5707403A (en) * | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
US5824005A (en) * | 1995-08-22 | 1998-10-20 | Board Of Regents, The University Of Texas System | Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias |
US6228078B1 (en) * | 1995-11-22 | 2001-05-08 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
US6206873B1 (en) * | 1996-02-13 | 2001-03-27 | El. En. S.P.A. | Device and method for eliminating adipose layers by means of laser energy |
US6638273B1 (en) * | 1996-03-05 | 2003-10-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
US6135997A (en) * | 1996-03-05 | 2000-10-24 | Vnus Medical Technologies, Inc. | Method for treating hemorrhoids |
US6033398A (en) * | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency using directionally applied energy |
US6139527A (en) * | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
US6273883B1 (en) * | 1996-04-09 | 2001-08-14 | Cynosure, Inc. | Alexandrite laser system for treatment of dermatological specimens |
US5820626A (en) * | 1996-07-30 | 1998-10-13 | Laser Aesthetics, Inc. | Cooling laser handpiece with refillable coolant reservoir |
US5976123A (en) * | 1996-07-30 | 1999-11-02 | Laser Aesthetics, Inc. | Heart stabilization |
US6197020B1 (en) * | 1996-08-12 | 2001-03-06 | Sublase, Inc. | Laser apparatus for subsurface cutaneous treatment |
US5789755A (en) * | 1996-08-28 | 1998-08-04 | New Star Lasers, Inc. | Method and apparatus for removal of material utilizing near-blackbody radiator means |
US6028316A (en) * | 1996-08-28 | 2000-02-22 | New Star Lasers, Inc. | Method and apparatus for removal of material utilizing near-blackbody radiator means |
US6451044B1 (en) * | 1996-09-20 | 2002-09-17 | Board Of Regents, The University Of Texas System | Method and apparatus for heating inflammed tissue |
US6290675B1 (en) * | 1997-01-09 | 2001-09-18 | Endosonics Corporation | Device for withdrawing a catheter |
US5810801A (en) * | 1997-02-05 | 1998-09-22 | Candela Corporation | Method and apparatus for treating wrinkles in skin using radiation |
US6361496B1 (en) * | 1997-06-02 | 2002-03-26 | Vnus Medical Technologies, Inc. | Pressure tourniquet with ultrasound window and method of use |
US5885274A (en) * | 1997-06-24 | 1999-03-23 | New Star Lasers, Inc. | Filament lamp for dermatological treatment |
US5968034A (en) * | 1997-06-24 | 1999-10-19 | Laser Aesthetics, Inc. | Pulsed filament lamp for dermatological treatment |
US6273885B1 (en) * | 1997-08-16 | 2001-08-14 | Cooltouch Corporation | Handheld photoepilation device and method |
US6413253B1 (en) * | 1997-08-16 | 2002-07-02 | Cooltouch Corporation | Subsurface heating of material |
US6083223A (en) * | 1997-08-28 | 2000-07-04 | Baker; James A. | Methods and apparatus for welding blood vessels |
US6258084B1 (en) * | 1997-09-11 | 2001-07-10 | Vnus Medical Technologies, Inc. | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US5984915A (en) * | 1997-10-08 | 1999-11-16 | Trimedyne, Inc. | Percutaneous laser treatment |
US6176854B1 (en) * | 1997-10-08 | 2001-01-23 | Robert Roy Cone | Percutaneous laser treatment |
US6263248B1 (en) * | 1997-11-12 | 2001-07-17 | Vnus Medical Technologies, Inc. | Catheter having expandable electrodes and adjustable stent |
US6014589A (en) * | 1997-11-12 | 2000-01-11 | Vnus Medical Technologies, Inc. | Catheter having expandable electrodes and adjustable stent |
US6200466B1 (en) * | 1998-02-23 | 2001-03-13 | New Star Lasers, Inc. | Decontamination of water by photolytic oxidation/reduction utilizing near blackbody radiation |
US6117335A (en) * | 1998-02-23 | 2000-09-12 | New Star Lasers, Inc. | Decontamination of water by photolytic oxidation/reduction utilizing near blackbody radiation |
US6306130B1 (en) * | 1998-04-07 | 2001-10-23 | The General Hospital Corporation | Apparatus and methods for removing blood vessels |
US6346105B1 (en) * | 1998-07-27 | 2002-02-12 | Quantum Cor Incorporated | Device for treating tissue and methods thereof |
US6224593B1 (en) * | 1999-01-13 | 2001-05-01 | Sherwood Services Ag | Tissue sealing using microwaves |
US6398777B1 (en) * | 1999-02-01 | 2002-06-04 | Luis Navarro | Endovascular laser device and treatment of varicose veins |
US6520975B2 (en) * | 1999-02-04 | 2003-02-18 | Antonio Carlos Branco | Kit for endovascular venous surgery |
US6270476B1 (en) * | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6200332B1 (en) * | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
US6451007B1 (en) * | 1999-07-29 | 2002-09-17 | Dale E. Koop | Thermal quenching of tissue |
US6761826B2 (en) * | 2001-11-30 | 2004-07-13 | New Star Lasers, Inc. | Pulsed blackbody radiation flux enhancement |
US20040010248A1 (en) * | 2002-07-10 | 2004-01-15 | Appling William M. | Endovascular treatment device having a fiber tip spacer |
US7160289B2 (en) * | 2003-03-28 | 2007-01-09 | Vandolay, Inc. | Vascular occlusion systems and methods |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238453B2 (en) | 2002-07-10 | 2019-03-26 | Angiodynamics, Inc. | Method of making an endovascular laser treatment device for causing closure of a blood vessel |
US10322296B2 (en) | 2009-07-20 | 2019-06-18 | Syneron Medical Ltd. | Method and apparatus for fractional skin treatment |
Also Published As
Publication number | Publication date |
---|---|
US20070123846A1 (en) | 2007-05-31 |
US7921854B2 (en) | 2011-04-12 |
US20160113714A1 (en) | 2016-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7921854B2 (en) | Endovenous laser treatment for varicose veins | |
JP6957545B2 (en) | Intraluminal treatment device | |
US8932338B2 (en) | Noninvasive method for site-specific fat reduction | |
US9782222B2 (en) | System and method for endovenous treatment of varicose veins with mid infrared laser | |
US20090182315A1 (en) | Laser liposuction system and method | |
US20130023855A1 (en) | Thermally mediated tissue molding | |
JP2009502212A (en) | Apparatus and method for cosmetic treatment of local lipodystrophy and slack | |
WO2008134589A1 (en) | Optical array for treating biological tissue | |
Gupta et al. | Intralesional cryosurgery using lumbar puncture and/or hypodermic needles for large, bulky, recalcitrant keloids | |
Sadick | Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure | |
JP5759367B2 (en) | Percutaneous vascular treatment method and apparatus | |
Weiss et al. | Endovenous ablation of truncal veins. | |
Morrison | Laser treatment of the incompetent saphenous vein | |
Raulin et al. | Treatment of benign venous malformations with an intense pulsed light source (PhotoDerm (R) VL) | |
US20130138033A1 (en) | Laser assisted sclerotherapy method for treating varicose veins | |
WO2010006082A1 (en) | Endoluminal laser ablation device and method for treating veins | |
Disselhoff et al. | Twenty years’ experience with endovenous laser ablation for varicose veins: a critical appraisal of the original procedure | |
Nootheti et al. | Review of intravascular approaches to the treatment of varicose veins | |
US8709004B2 (en) | Method and device for vascular treatment | |
Pandey et al. | Endoluminal treatments for varicose veins | |
Hsu | for Leg Veins | |
Whiteley | New methods of vein ablation | |
Lin et al. | Endovenous catheter ablation of the saphenous vein | |
Jindal et al. | Minimal Invasive Treatment of Varicose Veins | |
Weiss et al. | Endovenous Elimination of the Great Saphenous Vein with Radiofrequency or Laser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COOLTOUCH INCORPORATED, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HENNINGS, DAVID R.;GOLDMAN, MITCHEL P.;WEISS, ROBERT A.;AND OTHERS;REEL/FRAME:025448/0821 Effective date: 20091120 |
|
AS | Assignment |
Owner name: NEW STAR LASERS, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:COOLTOUCH INCORPORATED;REEL/FRAME:032150/0099 Effective date: 20030226 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |